Summary
Pharmaceuticals in Australia industry profile provides top-line qualitative and quantitative summary information including: market size (value 2016-20, and forecast to 2025). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.
Key Highlights
- The pharmaceuticals market consists of ethical drugs only and does not include consumer healthcare or animal healthcare.
- The Australian pharmaceuticals market had total revenues of $12.4bn in 2020, representing a compound annual growth rate (CAGR) of 2.4% between 2016 and 2020.
- Australia’s population is aging, with being 21-23% of the population estimated to be aged 65 and over by 2066. Chronic diseases are also becoming increasingly common, and overall, this will continue to drive the demand for pharmaceuticals in the country.
- Australia’s domestic pharmaceutical manufacturing capacity is likely to be boosted by the introduction of the Modern Manufacturing Initiative in 2021, which will contribute to market growth going forwards.
Scope
- Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the pharmaceuticals market in Australia
- Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the pharmaceuticals market in Australia
- Leading company profiles reveal details of key pharmaceuticals market players’ global operations and financial performance
- Add weight to presentations and pitches by understanding the future growth prospects of the Australia pharmaceuticals market with five year forecasts
Reasons to Buy
- What was the size of the Australia pharmaceuticals market by value in 2020?
- What will be the size of the Australia pharmaceuticals market in 2025?
- What factors are affecting the strength of competition in the Australia pharmaceuticals market?
- How has the market performed over the last five years?
- What are the main segments that make up Australia's pharmaceuticals market?
'
Table of Contents
1 Executive Summary
1.1. Market value
1.2. Market value forecast
1.3. Geography segmentation
1.4. Market share
1.5. Market rivalry
1.6. Competitive Landscape
2 Market Overview
2.1. Market definition
2.2. Market analysis
3 Market Data
3.1. Market value
4 Market Segmentation
4.1. Geography segmentation
5 Market Outlook
5.1. Market value forecast
6 Five Forces Analysis
6.1. Summary
6.2. Buyer power
6.3. Supplier power
6.4. New entrants
6.5. Threat of substitutes
6.6. Degree of rivalry
7 Competitive Landscape
7.1. Market share
7.2. Who are the leading players?
7.3. What are the strengths and weaknesses of leading players?
7.4. What strategies do leading players follow?
8 Company Profiles
8.1. Pfizer Inc.
8.2. Aspen Pharmacare Holdings Ltd
8.3. AstraZeneca PLC
8.4. GlaxoSmithKline Plc
9 Macroeconomic Indicators
9.1. Country data
10 Appendix
10.1. Methodology
10.2. Industry associations
10.3. Related MarketLine research
10.4. About MarketLine
List of Tables
Table 1: Australia pharmaceuticals market value: $ billion, 2016-20
Table 2: Australia pharmaceuticals market geography segmentation: $ billion, 2020
Table 3: Australia pharmaceuticals market value forecast: $ billion, 2020-25
Table 4: Australia pharmaceuticals market share: % share, by value, 2020
Table 5: Pfizer Inc.: key facts
Table 6: Pfizer Inc.: Annual Financial Ratios
Table 7: Pfizer Inc.: Key Employees
Table 8: Pfizer Inc.: Key Employees Continued
Table 9: Aspen Pharmacare Holdings Ltd: key facts
Table 10: Aspen Pharmacare Holdings Ltd: Annual Financial Ratios
Table 11: Aspen Pharmacare Holdings Ltd: Key Employees
Table 12: AstraZeneca PLC: key facts
Table 13: AstraZeneca PLC: Annual Financial Ratios
Table 14: AstraZeneca PLC: Key Employees
Table 15: GlaxoSmithKline Plc: key facts
Table 16: GlaxoSmithKline Plc: Annual Financial Ratios
Table 17: GlaxoSmithKline Plc: Annual Financial Ratios (Continued)
Table 18: GlaxoSmithKline Plc: Key Employees
Table 19: GlaxoSmithKline Plc: Key Employees Continued
Table 20: Australia size of population (million), 2016-20
Table 21: Australia gdp (constant 2005 prices, $ billion), 2016-20
Table 22: Australia gdp (current prices, $ billion), 2016-20
Table 23: Australia inflation, 2016-20
Table 24: Australia consumer price index (absolute), 2016-20
Table 25: Australia exchange rate, 2016-20
List of Figures
Figure 1: Australia pharmaceuticals market value: $ billion, 2016-20
Figure 2: Australia pharmaceuticals market geography segmentation: % share, by value, 2020
Figure 3: Australia pharmaceuticals market value forecast: $ billion, 2020-25
Figure 4: Forces driving competition in the pharmaceuticals market in Australia, 2020
Figure 5: Drivers of buyer power in the pharmaceuticals market in Australia, 2020
Figure 6: Drivers of supplier power in the pharmaceuticals market in Australia, 2020
Figure 7: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Australia, 2020
Figure 8: Factors influencing the threat of substitutes in the pharmaceuticals market in Australia, 2020
Figure 9: Drivers of degree of rivalry in the pharmaceuticals market in Australia, 2020
Figure 10: Australia pharmaceuticals market share: % share, by value, 2020
